Patent Assignment
Reel/Frame 044446/0779
Assignment of Assignor's Interest
Recorded: 2017-12-20
Pages: 9
Assignor
PRESCIENT NEUROPHARMA, INC.
Executed: 2007-11-30
Assignee
EMS DEVELOPMENT GROUP, LLC
9220 SCOTT DRIVE, ROCKVILLE, MARYLAND, 20850
Covered Properties
(2)
Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof
Application:
14/755,272 →
Publication:
US 2016/0152673
Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof
Application:
15/443,712 →
Publication:
US 2017/0298110
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Oct 13, 2015
From: AMARANTUS BIOSCIENCE HOLDINGS, INC.
To: DOMINION CAPITAL, LLC
Reel/Frame 036785/0158 →
Assignment of Assignor's Interest
Dec 20, 2017
From: COMMISSIONG, JOHN; RAIBEKAS, ANDREI
To: PRESCIENT NEUROPHARMA, INC.
Reel/Frame 044446/0772 →
Assignment of Assignor's Interest
Dec 20, 2017
From: EMS DEVELOPMENT GROUP, LLC
To: CNS PROTEIN THERAPEUTICS, INC.
Reel/Frame 044446/0808 →
Change of Name
Dec 20, 2017
From: CNS PROTEIN THERAPEUTICS, INC.
To: AMARANTUS THERAPEUTICS, INC.
Reel/Frame 044918/0879 →